Gabriel Morris's most recent trade in Immix Biopharma Inc was a trade of 156,000 Common Stock done at an average price of $0.8 . Disclosure was reported to the exchange on Dec. 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immix Biopharma Inc | Gabriel Morris | Director, CFO | 08 Dec 2025 | 156,000 | 426,844 | - | 0.8 | 124,800 | Common Stock | |
| Immix Biopharma Inc | Gabriel Morris | Director, CFO | 08 Dec 2025 | 96,000 | 0 | - | - | Warrants (right to purchase) | ||
| Immix Biopharma Inc | Gabriel Morris | Director, CFO | 08 Dec 2025 | 60,000 | 0 | - | - | Warrants (right to purchase) | ||
| Immix Biopharma Inc | Gabriel Morris | Director, CFO | Purchase of securities on an exchange or from another person at price $ 6.58 per share. | 08 Dec 2025 | 770 | 291,429 | - | 6.6 | 5,067 | Common Stock |
| Immix Biopharma Inc | Gabriel Morris | Director, CFO | Purchase of securities on an exchange or from another person at price $ 1.97 per share. | 16 Sep 2025 | 2,600 | 290,659 | - | 2.0 | 5,122 | Common Stock |
| Immix Biopharma Inc | Gabriel Morris | Director, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 340,000 | 340,000 | - | - | Stock Option (Right to Buy) | |
| Immix Biopharma Inc | Gabriel Morris | Director, CFO | Purchase of securities on an exchange or from another person at price $ 2.28 per share. | 18 Jun 2025 | 2,225 | 288,059 | - | 2.3 | 5,071 | Common Stock |
| Immix Biopharma Inc | Gabriel Morris | Director, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 340,000 | 340,000 | - | - | Stock Option (Right to Buy) | |
| Immix Biopharma Inc | Gabriel Morris | Director, CFO | Purchase of securities on an exchange or from another person at price $ 2.12 per share. | 07 Jun 2024 | 2,500 | 285,834 | - | 2.1 | 5,298 | Common Stock |
| Immix Biopharma Inc | Gabriel Morris | Director, CFO | Purchase of securities on an exchange or from another person at price $ 1.81 per share. | 04 Jun 2024 | 3,300 | 283,334 | - | 1.8 | 5,973 | Common Stock |
| Immix Biopharma Inc | Gabriel Morris | Director, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 194,218 | 280,034 | - | - | Common Stock | |
| Immix Biopharma Inc | Gabriel Morris | Director, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 24,141 | 24,141 | - | - | Common Stock | |
| Immix Biopharma Inc | Gabriel Morris | Director, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 24,141 | 270,844 | - | - | Common Stock | |
| Immix Biopharma Inc | Gabriel Morris | Director, CFO | Purchase of securities on an exchange or from another person at price $ 2.23 per share. | 14 May 2024 | 4,500 | 85,816 | - | 2.2 | 10,042 | Common Stock |
| Immix Biopharma Inc | Gabriel Morris | Director, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 193,000 | 193,000 | - | - | Stock Options | |
| Immix Biopharma Inc | Gabriel Morris | Director, CFO | Purchase of securities on an exchange or from another person at price $ 0.94 per share. | 14 Nov 2022 | 5,200 | 81,316 | - | 0.9 | 4,888 | Common Stock |
| Immix Biopharma Inc | Gabriel Morris | Director, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2022 | 250,000 | 716,500 | - | - | Stock Options | |
| Immix Biopharma Inc | Gabriel Morris | Director, Chief Financial Officer | 20 Dec 2021 | 123,527 | 123,527 | - | 0.9 | 104,998 | Common Stock | |
| Immix Biopharma Inc | Gabriel Morris | Director, Chief Financial Officer | 20 Dec 2021 | 123,176 | 246,703 | - | 0.9 | 104,700 | Common Stock | |
| Immix Biopharma Inc | Gabriel Morris | Director, Chief Financial Officer | 20 Dec 2021 | 74,116 | 74,116 | - | 0.9 | 62,999 | Common Stock | |
| Immix Biopharma Inc | Gabriel Morris | Director, Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 20 Dec 2021 | 2,000 | 76,116 | - | 5 | 10,000 | Common Stock |